First review cycle
This article was originally published in The Gray Sheet
Executive Summary
FDA is considering how product review can be reformed and made "more efficient and less painful for the industry," FDA Deputy Commissioner Lester Crawford reports March 20 at the AdvaMed annual meeting. The agency "will be having some committee meetings and also some public meetings" to gather ideas, he noted...